Martha Arnold has spent her career working with pharmaceutical companies, both in marketing and in regulatory communications. This experience, which has given her insight into the drug development and approval process, is a perspective she hopes to bring to the TMA Board. Martha was diagnosed with IBM November 2014. She lives near Philadelphia with her husband, Mark. They have a grown son, Eric, who lives nearby.